Edgewell Personal Care financials
$27.50−2.79%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q3 '26 Jun 30 | Q2 '26 Mar 31 | Q1 '26 Dec 31 | Q4 '25 Sep 30 | Q3 '25 Jun 30 | Q2 '25 Mar 31 | Q1 '25 Dec 31 | Q4 '24 Sep 30 | Q3 '24 Jun 30 | Q2 '24 Mar 31 | Q1 '24 Dec 31 | Q4 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $570.1M | $519.5M | $422.8M | $537.2M | $560.4M | $516.6M | $415.1M | $517.6M | $647.8M | $599.4M | $488.9M | $534.1M |
| Gross profit | $242.5M | $216.9M | $161.0M | $208.6M | $250.1M | $236.9M | $172.5M | $212.8M | $287.1M | $258.1M | $197.7M | $228.6M |
| Gross margin | 42.5% | 41.8% | 38.1% | 38.8% | 44.6% | 45.9% | 41.6% | 41.1% | 44.3% | 43.1% | 40.4% | 42.8% |
| Operating income | $25.0M | $18.4M | -$18.9M | -$36.3M | $45.0M | $49.0M | $9.3M | $20.4M | $82.7M | $70.1M | $26.1M | $52.1M |
| Net income | $13.7M | -$10.6M | -$65.7M | -$30.6M | $29.1M | $29.0M | -$2.1M | $8.8M | $49.0M | $36.0M | $4.8M | $29.9M |
| Net margin | 2.4% | −2.0% | −15.5% | −5.7% | 5.2% | 5.6% | −0.5% | 1.7% | 7.6% | 6.0% | 1.0% | 5.6% |
| Diluted EPS | $0.29 | $-0.22 | $-1.41 | $-0.66 | $0.62 | $0.60 | $-0.04 | $0.18 | $0.98 | $0.72 | $0.09 | $0.58 |
| EBITDA | $56.3M | $51.5M | $20.5M | $53.5M | $82.0M | $82.6M | $35.1M | $64.6M | $107.5M | $95.7M | $55.4M | $60.0M |
| Operating cash flow | $118.7M | $54.3M | -$125.9M | $74.1M | $114.8M | $45.1M | -$115.6M | $73.7M | $101.2M | $129.0M | -$72.9M | $47.8M |
| Free cash flow | $103.1M | $40.3M | -$137.5M | $46.5M | $99.3M | $28.0M | -$132.4M | $47.8M | $88.6M | $117.5M | -$79.4M | $29.4M |
| Diluted shares | 46.6M | 46.8M | 46.6M | 46.5M | 47.0M | 48.2M | 48.7M | 49.6M | 50.1M | 50.2M | 50.5M | 51.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $397.1M | $299.7M | $223.3M | $225.7M | $199.6M | $170.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.28B | $1.28B | $1.55B | $1.41B | $1.40B | $1.46B |
| Total assets | $3.54B | $3.53B | $3.77B | $3.76B | $3.79B | $3.77B |
| Total liabilities | $2.08B | $2.09B | $2.28B | $2.20B | $2.23B | $2.26B |
| Shareholders' equity | $1.46B | $1.45B | $1.49B | $1.55B | $1.57B | $1.51B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology